United Therapeutics Corporation (UTHR) Event Aug. 03, 2022, 00:00 UTC (47% Neutral) United Therapeutics Corporation (UTHR) Reports 44% Profit Decline for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:33 a.m. 🏢 United Therapeutics Corporation (UTHR) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-03 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $200.90M $355.90M $-155.00M -43.55% 📈 Total Assets $10.60M $10.40M $200.00K +1.92% ↗️ Total Liabilities $2.00M $2.50M $-500.00K -20.00% 📈 Stockholders' Equity $3.64B $4.04B $-400.60M -9.92% 📉 Operating Income/Loss $157.40M $489.80M $-332.40M -67.86% 📈 Gross Profit $765.40M $18.90M $746.50M +3949.74% 📈 R&D Expense $105.00M $378.00M $-273.00M -72.22% 📈 SG&A Expense $230.00M $220.50M $9.50M +4.31% ↗️ Earningspersharebasic $4.49 $7.86 $-3.37 -42.88% 📉 Earningspersharediluted $4.28 $7.43 $-3.15 -42.40% 📉 📈 Financial Trend Analysis ✅ Maintained profitability • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 United Therapeutics Corporation (UTHR) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
✅ Maintained profitability • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document